DGAP-News: MediClin AG: The Board of Management of MEDICLIN will be expanded - Dr. York Dhein will join on April 1st, 2021
DGAP-News: MediClin AG
/ Key word(s): Personnel
MediClin AG: The Board of Management of MEDICLIN will be expanded - Dr. York Dhein will join on April 1st, 2021
12.01.2021 / 14:00
The issuer is solely responsible for the content of this announcement.
Offenburg, January 12, 2021
The Board of Management of MEDICLIN will be expanded - Dr. York Dhein will join on April 1st, 2021
In its meeting on January 11, 2021, the Supervisory Board of MEDICLIN Aktiengesellschaft appointed Dr. med. York Dhein as additional member to the Management Board of MEDICLIN AG.
The 54-year-old is a specialist in internal medicine and, after working in a clinic, worked for a large company health insurance fund for several years, last as head of care and contract management. This was followed by five years as a consultant in the health care business of an international management consulting company. Since 2013 he has been a member of the board and later chairman of the board of Johannesbad Holding SE & Co. KG, a family-run group of companies with a clear profile as a health service provider with a focus on rehabilitation.
York Dhein stands up for a stronger position of rehabilitation in the health sector for years. He has an excellent branch network and is involved in the board of the VPKA (Association of Private Hospitals) Bavaria.
The Management Board welcomes the reinforcement in the top management of MEDICLIN. The demands on the health system will increase significantly in the future, and with it the challenges in the largest segment of MEDICLIN, the post-acute segment.
About MEDICLIN AG (Ticker: MED; WKN: 659 510)
MEDICLIN has around 8,500 beds / care places and employs about 10,500 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and the subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual and personal needs.
MEDICLIN - A company of the Asklepios Group.
12.01.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
Language: |
English |
Company: |
MediClin AG |
|
Okenstraße 27 |
|
77652 Offenburg |
|
Germany |
Phone: |
+49 (0)781 488-326 |
Fax: |
+49 (0)781 488-184 |
E-mail: |
[email protected] |
Internet: |
www.mediclin.de |
ISIN: |
DE0006595101 |
WKN: |
659510 |
Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: |
1160059 |
|
End of News |
DGAP News Service |
1160059 12.01.2021
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Umsatzerlöse1 |
609,08 |
645,11 |
673,09 |
659,86 |
673,14 |
704,70 |
730,07 |
EBITDA1,2 |
27,01 |
37,35 |
93,58 |
77,50 |
85,22 |
90,92 |
98,73 |
EBITDA-Marge3 |
4,43 |
5,79 |
13,90 |
11,74 |
12,66 |
12,90 |
|
EBIT1,4 |
6,62 |
15,06 |
22,41 |
0,15 |
11,56 |
19,52 |
12,72 |
EBIT-Marge5 |
1,09 |
2,33 |
3,33 |
0,02 |
1,72 |
2,77 |
1,74 |
Jahresüberschuss1 |
3,96 |
7,76 |
9,68 |
-0,04 |
1,49 |
9,72 |
-10,72 |
Netto-Marge6 |
0,65 |
1,20 |
1,44 |
-0,01 |
0,22 |
1,38 |
-1,47 |
Cashflow1,7 |
19,34 |
29,77 |
69,59 |
118,69 |
81,97 |
34,64 |
78,00 |
Ergebnis je Aktie8 |
0,08 |
0,16 |
0,20 |
-0,19 |
0,03 |
0,20 |
-0,23 |
Dividende8 |
0,05 |
0,05 |
0,05 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: PricewaterhouseCoopers
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Mediclin |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
659510 |
2,600 |
Halten |
123,50 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
10,00 |
19,19 |
0,52 |
19,55 |
KBV |
KCV |
KUV |
EV/EBITDA |
0,63 |
1,58 |
0,17 |
1,45 |
Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23 in % |
Hauptversammlung |
0,00 |
0,00 |
0,00 |
06.06.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
02.05.2025 |
31.07.2024 |
04.11.2024 |
28.03.2025 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
7,08% |
1,48% |
-5,11% |
-1,52% |
|
|